PRENEOPLASTIC SIGNIFICANCE OF HEPATIC IRON-FREE FOCI IN GENETIC HEMOCHROMATOSIS - A STUDY OF 185 PATIENTS

被引:126
作者
DEUGNIER, YM
CHARALAMBOUS, P
LEQUILLEUC, D
TURLIN, B
SEARLE, J
BRISSOT, P
POWELL, LW
HALLIDAY, JW
机构
[1] CTR HOSP REG & UNIV,INSERM,U49,F-35033 RENNES,FRANCE
[2] CTR HOSP REG & UNIV,ANAT & CYTOL PATHOL LAB,F-35033 RENNES,FRANCE
[3] ROYAL BRISBANE HOSP,DEPT PATHOL,BRISBANE,QLD 4029,AUSTRALIA
[4] QUEENSLAND INST MED RES,BRISBANE 4029,AUSTRALIA
关键词
D O I
10.1016/0270-9139(93)90225-C
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sublobular nodules of hepatocytes free of iron or exhibiting much less iron than the surrounding parenchyma, referred to in this study as iron-free-foci, are frequently found in the livers of patients with genetic hemochromatosis complicated by hepatocellular carcinoma. To test the hypothesis that such nodules are preneoplastic lesions, iron-free foci were sought in the initial liver biopsy specimens of 185 patients with untreated and uncomplicated genetic hemochromatosis. Iron-free foci were found in 14 (7.6%) patients, all men, aged from 38 to 76 yr, with heavy iron overload and with fibrosis or cirrhosis. Twelve patients with iron-free foci were followed for 0.9 to 15 yr (7 +/- 6 yr). In six (50%), HCC developed, compared with 2 (8%) from a control group consisting of 24 patients without IFF matched according to age, sex, degree of fibrosis, liver iron amount and follow-up duration. The mean number of iron-free foci per iron-free foci-positive specimen was 3.2 +/- 2.1. Ten patients had dysplastic aspects in their iron-free foci, and four had intrahepatocytic iron-positive inclusions at the periphery of iron-free foci. Proliferative cell nuclear antigen was positive in 75% of iron-free foci and in 24% +/- 21% of hepatocyte nuclei in iron-free foci. This study clearly demonstrates that iron-free foci are proliferative lesions and strongly suggests that such nodules are preneoplastic foci. Therefore the finding of IFF in the initial liver biopsy specimen from a patient with genetic hemochromatosis should lead to regular screening for hepatocellular carcinoma.
引用
收藏
页码:1363 / 1369
页数:7
相关论文
共 29 条
  • [1] BARRY M, 1971, LANCET, V1, P100
  • [2] BASSETT ML, 1984, GASTROENTEROLOGY, V87, P628
  • [3] BRADBEAR RA, 1985, J NATL CANCER I, V75, P81
  • [4] BRADBEAR RA, 1987, NEOPLASMS LIVER, P191
  • [5] BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557
  • [6] BRISSOT P, 1991, OXFORD TXB CLIN HEPA, P948
  • [7] CARIANI E, 1988, CANCER RES, V48, P6844
  • [8] LIVER PATHOLOGY IN GENETIC HEMOCHROMATOSIS - A REVIEW OF 135 HOMOZYGOUS CASES AND THEIR BIOCLINICAL CORRELATIONS
    DEUGNIER, YM
    LOREAL, O
    TURLIN, B
    GUYADER, D
    JOUANOLLE, H
    MOIRAND, R
    JACQUELINET, C
    BRISSOT, P
    [J]. GASTROENTEROLOGY, 1992, 102 (06) : 2050 - 2059
  • [9] PRIMARY LIVER-CANCER IN GENETIC HEMOCHROMATOSIS - A CLINICAL, PATHOLOGICAL, AND PATHOGENETIC STUDY OF 54 CASES
    DEUGNIER, YM
    GUYADER, D
    CRANTOCK, L
    LOPEZ, JM
    TURLIN, B
    YAOUANQ, J
    JOUANOLLE, H
    CAMPION, JP
    LAUNOIS, B
    HALLIDAY, JW
    POWELL, LW
    BRISSOT, P
    [J]. GASTROENTEROLOGY, 1993, 104 (01) : 228 - 234
  • [10] DIFFERENTIATION BETWEEN HETEROZYGOTES AND HOMOZYGOTES IN GENETIC HEMOCHROMATOSIS BY MEANS OF A HISTOLOGICAL HEPATIC IRON INDEX - A STUDY OF 192 CASES
    DEUGNIER, YM
    TURLIN, B
    POWELL, LW
    SUMMERS, KM
    MOIRAND, R
    FLETCHER, L
    LOREAL, O
    BRISSOT, P
    HALLIDAY, JW
    [J]. HEPATOLOGY, 1993, 17 (01) : 30 - 34